This article is more than 5 years old. Information may no longer be current.
Latest IBS news and research for physicians
Irritable bowel syndrome is the most common functional gastrointestinal disorder, according to the International Foundation for Functional Gastrointestinal Disorders. Worldwide prevalence has been estimated to affect anywhere from 9% to 23% of the population.
Marking Irritable Bowel Syndrome Awareness Month, Healio Internal Medicine presents the latest IBS news, research and perspectives.
Comprehensive self-management program benefits IBS patients
A comprehensive self-management program designed to improve quality of life and reduce symptoms in patients with IBS resulted in sustained changes in behavior after 1 year, according to new research data. Read more.
New Drugs and Diagnostics for IBS-D
According to experts interviewed by Healio Gastroenterology, a number of recent advances have been made in the diagnosis and treatment of diarrhea-predominant IBS (IBS-D), including the first validated biomarker for diagnosing IBS-D and a number of new drugs, one of which has a unique mechanism of action. Read more.
Low FODMAP diet may significantly improve IBS symptoms
Researchers observed that dietary fermentable oligosaccharides, disaccharides and monosaccharides and polyols — or FODMAPs — were linked to symptoms of IBS and variations in the metabolome, according to results from a controlled, single blind study. Read more.
Ebastine reduces symptoms in patients with IBS
Ebastine, a histamine receptor H1 antagonist, was found to reduce visceral hypersensitivity, symptoms and abdominal pain in patients with IBS in a recent study. Read more.
The Diet Debate in IBS
A revitalized interest in dietary therapies for irritable bowel syndrome is marked by accumulating data presented in the journals and at leading scientific meetings in recent years, much of which is promising, according to experts interviewed by Healio Gastroenterology. Read more.
Migraine, tension headaches may be genetically linked to IBS
Migraine and tension headaches may have genetic links in common with IBS, according to results from a preliminary study released in advance of the American Academy of Neurology’s 68th Annual Meeting in Vancouver, Canada. Read more.
Risk factors for IBS in military include stress, infectious gastroenteritis
New research confirms previous findings that stress and infectious gastroenteritis are associated with new-onset IBS among members of the U.S. military. Read more.
Low FODMAPs Diet in IBS: Experts Disagree on Evidence of Efficacy
Interest in dietary interventions for IBS has seen a recent revival, prompted by randomized controlled trial data suggesting elimination diets — namely, the gluten-free diet and the low fermentable oligo, disaccharides, monosaccharaides, and polyols, or low FODMAPs, diet — may be effective for treating patients. Emerging data on the potential efficacy of probiotics in IBS have also sparked increasing interest as the role of the gut microbiome in GI disorders becomes better understood. Read more.
Global IBS prevalence among adults difficult to determine
Data from a literature review demonstrate that despite the numerous studies performed worldwide to ascertain IBS prevalence among adults, study methodologies are not uniform, leaving clinicians with a lack of reliable global prevalence data. Read more.